Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.01156
Abstract: The spread of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), firstly detected in Wuhan (China) at the end of 2019, has rapidly reached pandemic status. At the present time, under the “pressure” of… read more here.
Keywords: covid patients; oral idasanutlin; covid; considering oral ... See more keywords